ID: ALA4863321

Max Phase: Preclinical

Molecular Formula: C29H32FN3O5S

Molecular Weight: 553.66

Molecule Type: Unknown

Representations

Canonical SMILES:  CN(C(=O)c1ccc(N(CCN2CCCC2)S(=O)(=O)c2ccc(F)cc2)cc1)[C@@H](Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C29H32FN3O5S/c1-31(27(29(35)36)21-22-7-3-2-4-8-22)28(34)23-9-13-25(14-10-23)33(20-19-32-17-5-6-18-32)39(37,38)26-15-11-24(30)12-16-26/h2-4,7-16,27H,5-6,17-21H2,1H3,(H,35,36)/t27-/m0/s1

Standard InChI Key:  SESRJRLBHQWLSW-MHZLTWQESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 553.66

Molecular Weight (Monoisotopic): 553.2047

AlogP: 3.88

#Rotatable Bonds: 11

Polar Surface Area: 98.23

Molecular Species: ACID

HBA: 5

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 3.14

CX Basic pKa: 7.43

CX LogP: 1.53

CX LogD: 1.31

Aromatic Rings: 3

Heavy Atoms: 39

QED Weighted: 0.39

Np Likeness Score: -1.30

References

1. Laura M, Ronan G, Vy LB, Valentin G, Omar CA, Virgyl C, Piveteau C, Melissa R, Charlotte F, Sandrine W, Julie C, Julie DR, Damien B, Florence L, Peter VE, Benoit D, Rebecca DP..  (2021)  Modulators of hERAP2 discovered by high-throughput screening.,  211  [PMID:33359953] [10.1016/j.ejmech.2020.113053]

Source

Source(1):

• Scientific Literature